Innovative Ultrasound Technique Validated for Noninvasive Central Venous Pressure Measurement
A groundbreaking study validates a noninvasive ultrasound method to accurately measure central venous pressure, offering a safer alternative to invasive procedures and improving patient management in cardiovascular care.
A recent clinical pilot study has demonstrated the effectiveness of a novel noninvasive method to measure central venous pressure (CVP) using quantitative compression ultrasound (QCU). Conducted by researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH), this advancement offers a promising alternative to traditional invasive techniques, which often involve risks and require significant resources.
The study enrolled 11 patients from MGH's cardiac intensive care unit, all with standard central venous catheters. Researchers captured QCU data, including high-resolution ultrasound images of the internal jugular vein (IJV), while simultaneously recording the force applied to the skin surface. These measurements were then compared to the gold-standard invasive CVP readings obtained directly from the catheters. In addition, jugular venous pulsation height (JVP), a common noninvasive clinical measurement, was assessed in some patients for comparison.
Results showed a strong correlation between the force needed to fully occlude the IJV, known as the collapse force (CF), and invasive CVP measurements. Statistical analysis revealed an r² value of 0.82, with a mean absolute error just over 1 mmHg. When accounting for hydrostatic pressure, the correlation slightly improved to 0.83. Conversely, JVP showed a weaker correlation with CVP, with an r² of 0.45.
The implications of these findings are significant for clinical practice. Accurate and noninvasive CVP assessment can enhance patient management in conditions like heart failure and sepsis, where CVP guides treatment decisions. Compared to invasive methods, QCU reduces risk, discomfort, and resource utilization, and surpasses traditional methods like JVP in reliability.
Led by experts from MIT and Harvard Medical School, including Alex T. Jaffe, Roger Pallarès-López, Jeffrey K. Raines, and Aaron D. Aguirre, this research paves the way for broader application of ultrasound technology in patient care. The study underscores the potential of QCU to transform circulatory assessment by enabling more frequent, safe, and precise monitoring, particularly in settings constrained by resources.
Source: https://medicalxpress.com/news/2025-05-noninvasive-ultrasound-method-central-venous.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Can Multiple Tattoos Lower Skin Cancer Risk? Insights from Recent Research
Emerging research suggests that having multiple tattoos may be linked to a lower risk of melanoma, but experts caution against interpreting tattoos as a protective factor. Learn about the findings and limitations of recent studies on tattoos and skin cancer risk.
Understanding Autism Myths: From 'Refrigerator Mothers' to Misleading Claims about Acetaminophen
Explore the history of harmful autism myths, from 20th-century theories blaming mothers to recent false claims about acetaminophen. Learn how science debunks these misconceptions and promotes acceptance.
The Role of FGF21 Hormone in Reversing Fatty Liver Disease
New research shows that the hormone FGF21 can effectively reverse fatty liver disease by signaling the brain to improve liver health and reduce fibrosis, opening new therapeutic possibilities.
Prenatal Cannabis Exposure May Disrupt Reproductive Development Across Generations
A groundbreaking study links cannabis use during pregnancy to delayed reproductive development in female offspring, with effects spanning multiple generations. Learn more about the implications for maternal and long-term reproductive health.